Design and Baseline Data from Hephaistos Study Evaluating Efficacy and Safety of Early Initiation of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients

被引：0
|
作者：
Nashan, Bjorn [1 ]
Schemmer, Peter [1 ]
Braun, Felix [1 ]
Dworak, Markus [1 ]
Wimmer, Peter [1 ]
Schlitt, Hans [1 ]
机构：
[1] Hephaistos Study Grp, Nurnberg, Germany
来源：
TRANSPLANTATION | 2015年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-270
引用
收藏
页码：214 / 215
页数：2
相关论文
共 50 条
  • [1] HEPHAISTOS STUDY: DESIGN AND BASELINE DATA FROM EARLY INITIATION OF EVEROLIMUS-BASED TACROLIMUS REDUCTION IN DE NOVO LIVER TRANSPLANT RECIPIENTS
    Nashan, B.
    Schemmer, P.
    Braun, F.
    Dworak, M.
    Wimmer, P.
    Schlitt, H.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 316 - 316
  • [2] EARLY EVEROLIMUS-BASED TACROLIMUS REDUCTION IN DE NOVO LIVER TRANSPLANT RECIPIENTS: DESIGN AND BASELINE DATA FROM HEPHAISTOS STUDY
    Nashan, B.
    Schemmer, P.
    Braun, F.
    Dworak, M.
    Wimmer, P.
    Schlitt, H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S850 - S850
  • [3] SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
    Schlitt, H. J.
    Nashan, B.
    Schemmer, P.
    Pascher, A.
    Klein, C. G.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Braun, F.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 25 - 25
  • [4] HEPHAISTOS study: Early use of everolimus plus reduced tacrolimus in de novo liver transplant recipients achieves high efficacy and safety compared to standard tacrolimus.
    Schemmer, P.
    Nashan, B.
    Braun, F.
    Pascher, A.
    Klein, C. -G
    Neumann, U.
    Kroeger, I
    Wimmer, P.
    Schlitt, H. J.
    TRANSPLANTATION, 2019, 103 (08) : 298 - 298
  • [5] Early Use of Everolimus Plus Reduced Tacrolimus vs Standard Tacrolimus in De Novo Livertransplant Recipients: 12 Months Efficacy and Safety Data from HEPHAISTOS Study
    Nashan, B.
    Schemmer, P.
    Schlitt, H.
    Pascher, A.
    Klein, C.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Braun, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 333 - 333
  • [6] EFFICACY AND SAFETY OF EARLY USE OF REDUCED TACROLIMUS IN COMBINATION WITH EVEROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVERTRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
    Schemmer, Peter
    Braun, Felix
    Schlitt, Hans J.
    Pascher, Andreas
    Klein, Christian-Georg
    Neumann, Ulf
    Kroeger, Irena
    Wimmer, Peter
    Nashan, Bjoern
    TRANSPLANT INTERNATIONAL, 2019, 32 : 218 - 219
  • [7] Improvement of renal function with everolimus plus reduced tacrolimus in de novo liver transplant recipients - HEPHAISTOS study 12 month data.
    Schlitt, H. J.
    Nashan, B.
    Braun, F.
    Pascher, A.
    Klein, C. -G
    Neumann, U.
    Kroeger, I
    Wimmer, P.
    Schemmer, P.
    TRANSPLANTATION, 2019, 103 (08) : 46 - 46
  • [8] EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IMPROVES KIDNEY FUNCTION VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
    Braun, F.
    Nashan, B.
    Pascher, A.
    Klein, C. G.
    Schemmer, P.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Schlitt, H. J.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 24 - 24
  • [9] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED TACROLIMUS IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS: DESIGN AND BASELINE CHARACTERISTICS OF CRADLE STUDY
    Martins, S.
    Pape, L.
    Toenshoff, B.
    Dello Strologo, L.
    Ettenger, R.
    Martzloff, D.
    Lopez, P.
    Vergara, M.
    Ng, J.
    PEDIATRIC TRANSPLANTATION, 2015, 19 : 70 - 70
  • [10] Efficacy and Safety of Everolimus With Reduced Tacrolimus in Living-Donor Liver Transplant Recipients: Baseline Data from the H2307 Study
    Levy, G.
    Suh, K. S.
    Joh, J. W.
    Yoshizumi, T.
    Lee, W. C.
    Genyk, Y.
    Grant, D.
    Martzloff, E. -D.
    Sips, C.
    Wang, Z.
    Lopez, P.
    TRANSPLANTATION, 2015, 99 : 150 - 150
12345